PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-16.50%
Revenue decline while CRK shows 14.26% growth. Joel Greenblatt would examine competitive position erosion.
5.68%
Cost increase while CRK reduces costs. John Neff would investigate competitive disadvantage.
-25.93%
Gross profit decline while CRK shows 93.91% growth. Joel Greenblatt would examine competitive position.
-11.30%
Margin decline while CRK shows 69.71% expansion. Joel Greenblatt would examine competitive position.
No Data
No Data available this quarter, please select a different quarter.
-14.81%
G&A reduction while CRK shows 2.47% growth. Joel Greenblatt would examine efficiency advantage.
No Data
No Data available this quarter, please select a different quarter.
-92.39%
Both companies reducing other expenses. Martin Whitman would check industry patterns.
-14.53%
Operating expenses reduction while CRK shows 2.47% growth. Joel Greenblatt would examine advantage.
-4.75%
Both companies reducing total costs. Martin Whitman would check industry trends.
-10.23%
Interest expense reduction while CRK shows 11.72% growth. Joel Greenblatt would examine advantage.
3.21%
D&A growth above 1.5x CRK's 1.39%. Michael Burry would check for excessive investment.
-23.73%
EBITDA decline while CRK shows 14.49% growth. Joel Greenblatt would examine position.
-17.13%
EBITDA margin decline while CRK shows 10.20% growth. Joel Greenblatt would examine position.
-35.41%
Operating income decline while CRK shows 339.73% growth. Joel Greenblatt would examine position.
-22.65%
Operating margin decline while CRK shows 284.86% growth. Joel Greenblatt would examine position.
110.91%
Other expenses growth while CRK reduces costs. John Neff would investigate differences.
-24.65%
Pre-tax income decline while CRK shows 6.98% growth. Joel Greenblatt would examine position.
-9.77%
Pre-tax margin decline while CRK shows 18.59% growth. Joel Greenblatt would examine position.
-233.33%
Tax expense reduction while CRK shows 18.85% growth. Joel Greenblatt would examine advantage.
-23.20%
Net income decline while CRK shows 6.49% growth. Joel Greenblatt would examine position.
-8.03%
Net margin decline while CRK shows 18.16% growth. Joel Greenblatt would examine position.
-22.73%
EPS decline while CRK shows 9.94% growth. Joel Greenblatt would examine position.
-22.73%
Diluted EPS decline while CRK shows 9.94% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.